|
2017 Conference Publication Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trialPender, Michael, Csurhes, Peter, Smith, Corey, Douglas, Nanette, Neller, Michelle, Beagley, Leone, Rehan, Sweera, Hopkins, Tracey, Thompson, Kate, Blum, Stefan, Green, Kerryn, Ioannides, Zara, Coulthard, Alan, Hooper, Kaye, Burrows, Scott and Khanna, Rajiv (2017). Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated with autologous Epstein-Barr virus-specific T cell therapy: interim results of a phase I trial. 69th Annual Meeting of the American Academy of Neurology (AAN), Boston, Massachusetts, 22-28 April 2017. Philadelphia, PA, United States: Lippincott Williams & Wilkins. |
|
2017 Conference Publication Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosisPender, M. P., Csurhes, P. A., Smith, C., Douglas, N. L., Neller, M. A., Beagley, L., Rehan, S., Hopkins, T. J., Thompson, K. M., Blum, S., Green, K. A., Ioannides, Z. A., Coulthard, A., Hooper, K. D., Burrows, S. R. and Khanna, R. (2017). Safety and clinical improvement in a phase I trial of autologous Epstein-Barr virus-specific T-cell therapy in patients with progressive multiple sclerosis. 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), Paris, France, 25-28 October 2017. London, United Kingdom: Sage Publications. |
|
2015 Conference Publication Impaired T cell control of Epstein-Barr virus infection in multiple sclerosisPender, Michael, Csurhes, Peter and Burrows, Scott (2015). Impaired T cell control of Epstein-Barr virus infection in multiple sclerosis. MS Research Australia Progress in MS Research Conference, Melbourne, Australia, Oct 29-30, 2015. London, EC1Y 1SP United Kingdom: SAGE PUBLICATIONS LTD. doi: 10.1177/1352458515616527 |
|
2014 Conference Publication Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndromeBlum, Stefan, Csurhes, Peter, Reddel, Stephen, Spies, Judy and McCombe, Pamela (2014). Killer immunoglobulin-like receptors and their HLA ligands in Guillain-Barré syndrome. ANZAN Annual Scientific Meeting 2014, Adelaide, South Australia, Australia, May 2014. Elsevier. doi: 10.1016/j.jocn.2014.06.032 |
|
2013 Conference Publication Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapyPender, M. P., Csurhes, P. A., Smith, C., Beagley, L., Hooper, K. D., Raj, M., Coulthard, A., Burrows, S. R. and Khanna, R. (2013). Treatment of secondary progressive multiple sclerosis by boosting CD8 T cell immunity to Epstein-Barr virus using a novel adoptive immunotherapy. 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen Denmark, 2 - 5 October 2013. London, United Kingdom: Sage Publications Ltd.. doi: 10.1177/1352458513502429 |
|
2011 Conference Publication CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosisPender, M. P., Csurhes, P. A., Pfluger, C. M. M. and Burrows, S. R. (2011). CD8+T cell deficiency impairs control of Epstein-Barr virus and worsens with age in multiple sclerosis. LONDON: SAGE PUBLICATIONS LTD. |
|
2008 Conference Publication Role of autoreactivity against myelin proteolipid protein in multiple sclerosisGreer, Judith, Csurhes, Peter, Muller, Diane and Pender, Michael (2008). Role of autoreactivity against myelin proteolipid protein in multiple sclerosis. ISNI 2008: 9th International Congress of Neuroimmunology, Fort Worth, TX, U.S.A., October 26-30, 2008. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jneuroim.2008.08.001 |
|
2008 Conference Publication Infection with specific strains of Epstein-Barr virus are a risk factor for multiple sclerosisBrennan, Rebekah M., Burrows, Jacqueline M., Bell, Melissa J., Lenarczyk, Aleksandra, Csurhes, Peter A., Pender, Michael. and Burrows, Scott R. (2008). Infection with specific strains of Epstein-Barr virus are a risk factor for multiple sclerosis. Joint World Congress on Treatment and Research in Multiple Sclerosis: 13th Annnual Meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis / 24th Congress of the European Committee for Treatment and Research in Multiple Sclerosis / 5th Congress of the Latin American Committee for Treatment and Research in Multiple Sclerosis, Montréal, QC, Canada, 17-20 September 2008. London, U.K.: Sage Publications. doi: 10.1177/1352458508096399 |
|
2006 Conference Publication T-cell reactivity to myelin proteolipid protein drives the development of brainstem and cerebellar lesions in multiple sclerosisPender, M. P., Csurhes, P. A. and Greer, J. M. (2006). T-cell reactivity to myelin proteolipid protein drives the development of brainstem and cerebellar lesions in multiple sclerosis. 8th International Conference on Neuroimmunology, Nagoya, Japan, 15-19 October 2006. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.jneuroim.2006.07.002 |
|
2005 Conference Publication HLA-DR2 is associated with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in females, but not malesMcCombe, P. A., Csurhes, P. A., Alizart, M. A. and Greer, J. M. (2005). HLA-DR2 is associated with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in females, but not males. 5th Annual Meeting of the Federation-of-Clinical-Immunology-Society, Boston, MA, U.S.A., 12-16 May 2005. Orlando, Florida: Academic Press. |
|
2004 Conference Publication Clinical and immunological findings in patients with concurrent MS and autoimmune thyroid diseaseGreer, J. M., Tan, K. M., Wolfe, N. P., Csurhes, P. A. and Pender, M. P. (2004). Clinical and immunological findings in patients with concurrent MS and autoimmune thyroid disease. ACTRIMS 03, San Francisco, 19 October, 2003. United Kingdom: Arnold. |
|
2002 Conference Publication Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosisPender, M. P., Csurhes, P. A., Wolfe, N. P., Cameron, K. D., McCombe, P. A., Greer, J. M. and Good, M. F. (2002). Blood T-cell reactivity to gangliosides GM3 and GQ1b is increased in patients with primary progressive multiple sclerosis. 127th Annual Meeting of the American Neurological Association, New York City, NY, USA, October 12-16 2002. NEW YORK: WILEY-LISS. |
|
2002 Conference Publication T cell responses to gangliosides in patients with inflammatory neuropathyMcCombe, P. A., Sullivan, A. A., Alizart, M. A., Csurhes, P. A., Greer, J. M. and Pender, M. P. (2002). T cell responses to gangliosides in patients with inflammatory neuropathy. Xth International Congress on Neuromuscular Diseases, Vancouver, Canada, 07-12 Jul 2002. Amsterda, The Netherlands: Elseiver. doi: 10.1016/S0022-510X(02)80069-7 |
|
1999 Conference Publication Fluctuations in the frequencies of circulating myelin-reactive T cells in healthy subjects and patients with multiple sclerosisPender, M. P., Csurhes, P. A., Greer, J. M., Mowat, P. D., Henderson, R. D., Cameron, K. D., McCombe, P. A. and Good, M. F. (1999). Fluctuations in the frequencies of circulating myelin-reactive T cells in healthy subjects and patients with multiple sclerosis. ECTRIMS/ACTRIMS'99, Basel, Switzerland, 15 - 18 Sept, 1999. Basingstoke, England: Stockton Press. |
|
1999 Conference Publication The role of PMP-22 as an autoantigen in GBS and CIDPSullivan, A., Csurhes, P. A., Alizart, M., Pender, M. P. and McCombe, P. A. (1999). The role of PMP-22 as an autoantigen in GBS and CIDP. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., 21 - 27 Oct, 1999. Brisbane: Royal Brisbane Hospital. |
|
1998 Conference Publication The frequency of circulating T cells reactive to PLP184-209 increases prior to MS relapse and development of new MR1 lesionsCameron, K. D., Csurhes, P. A., Good, M. F., Greer, J. M., Henderson, R. D., McCombe, P. A., Mowat, P. D. and Pender, M. P. (1998). The frequency of circulating T cells reactive to PLP184-209 increases prior to MS relapse and development of new MR1 lesions. Fifth International Congress of the International Society of Neuroimmunology, Montreal, QC, Canada, 23-27 August 1998. doi: 10.1016/S0165-5728(98)91636-8 |
|
1996 Conference Publication T-cell reactivity to peptides of proteolipid protein and myelin basic protein in multiple sclerosisPender, M. P., Greer, J. M., Csurhes, P. A., Cameron, K. D., McCombe, P. A. and Good, M. F. (1996). T-cell reactivity to peptides of proteolipid protein and myelin basic protein in multiple sclerosis. 121st Annual Meeting of the American Neurological Association, Miami, FL, U.S.A., 13-16 October 1996. BOSTON: LITTLE BROWN CO. doi: 10.1002/ana.410400326 |
|
1995 Conference Publication Reactivity to myelin proteolipid protein in multiple sclerosis patientsCameron, K., Csurhes, P., Greer, J., McCombe, P. and Pender, M. (1995). Reactivity to myelin proteolipid protein in multiple sclerosis patients. The 9th International Congress of Immunology, San Francisco, California, USA, 23-29 July 1995. San Francisco, California, USA: American Association of Immunologists and the International Union of Immunological Societies. |
|
1993 Conference Publication Human T cell responses to myelin basic protein isoformsMcCombe, P. A., Csurhes, P. A., Houghten, R. A., Good, M. F. and Pender, M. P. (1993). Human T cell responses to myelin basic protein isoforms. International Congress on the Regulation of Leukocyte Production and Immune Function held at the Joint Meeting of the Australasian Society for Immunology and Society for Leukocyte Biology, Sydney, New South Wales, Australia, 1-5 December 1993. Bethesda, MD, United States: Federation of American Societies for Experimental Biology. |
|
1990 Conference Publication Amino acid sequences recognized by T-cells: studies on a merozoite surface antigen from the FCQ27/PNG isolate of Plasmodium falciparumRzepczyk, C. M., Csurhes, P. A., Baxter, E. P., Doran, T. J., Irving, D. O. and Kere, N. (1990). Amino acid sequences recognized by T-cells: studies on a merozoite surface antigen from the FCQ27/PNG isolate of Plasmodium falciparum. International Conference on Cellular Mechanisms in Malaria Immunity, Bethesda, MD, United States, 3-6 April 1990. Amsterdam, Netherlands: Elsevier. doi: 10.1016/0165-2478(90)90108-3 |
